Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Of the various techniques, the texture-based classification of CT images holds promise for distinguishing between benign and metastatic liver lesions (94)
3, eds DolphinD.PoulsonR.AvramovicO
Reported side effects are similar to other GLP medications: Mild nausea Decreased appetite Occasional vomiting or diarrhea Fatigue during dose escalation Most effects are temporary and improve as the body adjusts to treatment
Blood glucose monitoring and any necessary adjustments to insulin or sulfonylurea doses should be managed under the supervision of the trial team or treating clinician
The timeline for FDA approval, based on typical phase 3 durations and regulatory review windows, points toward a potential submission in 2025 or 2026, with approval plausibly following in 2026 or 2027
Like other GLP-1 weight-loss injections, Wegovy helps you feel fuller for longer
